Results 31 - 40 of 188 : Previous 1 2 3 4 5 6 7 8 9 Next
Get the facts before jumping on this one.
Consider this before you invest solo.
Dendreon: Cash Out or Keep Riding Up?
Given the rise this year and Provenge's prospects, what should a prudent investor do?
Dendreon Is No Dot-Com Story ... Yet
It's a biotech thing.
Comparative Medicine Could Sink Your Stocks
Does comparative medicine mean the death of the me-too drug? Or your stocks?
Is Dendreon Just a Dot-Com Story at This Price?
The stock has had a really good year, but now it's time to lock in the gains.
Top-Rated Stocks That Treat Shareholders Right
These high-flying investments come with good corporate governance policies.
This bullish call comes from more than just one analyst.
1-Star Stocks Poised to Plunge: Antigenics?
Market-lagging returns could be written in this one-star stock.
Johnson & Johnson and Bayer can catch up, though.